We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Results of Lung Cancer CT Screening Show Impact on Death Rates

By MedImaging International staff writers
Posted on 01 Aug 2016
A new trial has found that lung cancer screening and early detection of lung cancer can prolong the lives of 70% of patients by one year or more.

In addition, the researchers also studied the long-term psychosocial outcomes of Computed Tomography (CT) lung cancer screening and found that screening did not result in unnecessary anxiety. The researchers did find that participants may face barriers such as fear and stigma that prevent their participation in a screening program.

The results of the trial were published in the July 2016 issue of the journal Thorax. The UK Lung cancer Screening trial (UKLS) was led by researchers at Cardiff University (Cardiff, UK), and included more than 4,000 women, and men, between 50 and 75 years old, who had a high risk of contracting lung cancer.

The results of the trial are intended to guide UK clinical and policy decisions for the implementation of potential future low-dose CT lung cancer screening for high-risk patients.

Dr. Kate Brain, Cardiff University, said, "With the UK's five-year survival rate for lung cancer being lower than many other countries with comparable healthcare systems, it is important that we do more to introduce early detection strategies that help to ensure treatment is delivered before patients present at an advanced stage of the disease. Sometimes, fear of medical procedures and the results they might bring can prevent people from seeking life-saving tests. However, what our trial shows is that CT lung cancer screening actually has no long-term negative psychosocial impact on patients, making it an excellent tool for catching lung cancer earlier when there is a better chance of survival."

Related Links:
Cardiff University


X-Ray Illuminator
X-Ray Viewbox Illuminators
New
Cylindrical Water Scanning System
SunSCAN 3D
Ultrasound Table
Women’s Ultrasound EA Table
New
Radiation Shielding
Oversize Thyroid Shield
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.